Publisher
Springer Science and Business Media LLC
Subject
Biochemistry (medical),Clinical Biochemistry,Endocrinology,Endocrinology, Diabetes and Metabolism
Reference12 articles.
1. Fonseca L, Paredes S, Ramos H, Oliveira JC, Palma I. Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoproteincholesterol. Lipids Health Dis. 2020;19:127.
2. Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37:2999–3058.
3. Kurmus O, Erkan AF, Ekici B, Aslan T, Eren M. Discordance of low-density lipoprotein Cholestrol and non-high-density lipoprotein Cholestrol and coronary artery disease severity. Arq Bras Cardiol. 2020;114:469–75.
4. Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB. Non-highdensity lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation. 2005;112:3375–83.
5. Kattoor AJ, Kanuri SH, Mehta JL. Role of ox-LDL and LOX-1 in Atherogenesis. Curr Med Chem. 2019;26:1693–700.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献